Understanding the financial impact of covering new screening technologies: The case of automated Pap smears

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 45, Issue 11, 2000, Pages 898-906

  McQuarrie, H G ^a   Ogden, J ^a   Costa, M ^a  

^a NONE   (United States)

Author keywords

Cervical smears; Computer assisted; Costs and cost analysis; Diagnosis; Papanicolaou smear

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; FEMALE; FINANCIAL MANAGEMENT; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MANAGED CARE; PAPANICOLAOU TEST; PATIENT CARE; PRIORITY JOURNAL; REIMBURSEMENT; SCREENING TEST;

EID: 0033645245     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. The actuary's role in managed care
2. The AutoPap® System for primary screening in cervical cytology, comparing the results of a prospective, intended-use study with routine manual practice